S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.14%) $0.928
USD/NOK
(0.29%) $10.87
USD/GBP
(0.01%) $0.792
USD/RUB
(0.05%) $92.62

Realtime updates for Vaxcyte Inc [PCVX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
45.00%
return -9.53%
SELL
50.00%
return 0.75%
Last Updated28 Mar 2024 @ 16:00

-0.28% $ 68.31

BUY 3484 min ago

@ $67.25

Issued: 26 Mar 2024 @ 15:46


Return: 1.58%


Previous signal: Mar 26 - 12:12


Previous signal: Sell


Return: -0.03 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia...

Stats
Today's Volume 674 974
Average Volume 875 885
Market Cap 7.41B
EPS $0 ( 2024-02-27 )
Next earnings date ( $-1.110 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -16.50
ATR14 $2.14 (3.12%)
Insider Trading
Date Person Action Amount type
2024-03-25 Pickering Grant Buy 15 000 Common Stock
2024-03-25 Pickering Grant Sell 13 450 Common Stock
2024-03-25 Pickering Grant Sell 1 550 Common Stock
2024-03-25 Pickering Grant Sell 15 000 Stock Option (Right to Buy)
2024-03-18 Guggenhime Andrew Sell 8 000 Stock Option (right to buy)
INSIDER POWER
32.16
Last 100 transactions
Buy: 813 250 | Sell: 420 856

Volume Correlation

Long: -0.52 (weak negative)
Short: -0.58 (weak negative)
Signal:(42) Neutral

Vaxcyte Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vaxcyte Inc Correlation - Currency/Commodity

The country flag 0.55
( weak )
The country flag 0.51
( weak )
The country flag 0.00
( neutral )
The country flag 0.61
( weak )
The country flag 0.46
( neutral )
The country flag -0.31
( neutral )

Vaxcyte Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-10.17M (0.00 %)
EPS: $-4.14
Q4 2023
Revenue: $0
Gross Profit: $-2.95M (0.00 %)
EPS: $-1.900
Q3 2023
Revenue: $0
Gross Profit: $-2.48M (0.00 %)
EPS: $-0.910
Q2 2023
Revenue: $0
Gross Profit: $-2.40M (0.00 %)
EPS: $-0.700

Financial Reports:

No articles found.

Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators